Pelosi: 'Today's Sweeping, Bipartisan Legislation to Improve Drug Safety is a Victory for All Americans'
Posted on: Wednesday, 19 September 2007, 21:00 CDT
WASHINGTON, Sept. 19 /PRNewswire-USNewswire/ -- Speaker Nancy Pelosi issued the following statement today on H.R. 3580, FDA Amendments/Improving Drug Safety Act, which passed by a vote of 405 to 7:
"Today's sweeping, bipartisan legislation to improve drug safety is a victory for all Americans.
"Essential to the safety net of our country is the right of every American to know that the prescription drugs they buy are safe. These long overdue reforms will better protect the health of Americans. The bill creates a new Food and Drug Administration initiative to monitor the safety of drugs after they are on the market. It also ensures the FDA acts based on objective information and is not tainted by conflict-of-interest. And it increases penalties against prescription drug companies that violate the FDA standards that keep Americans safe.
"By strengthening drug safety in our nation, we are keeping our commitment to care for America's families."
Office of the Speaker of the House
CONTACT: Brendan Daly or Nadeam Elshami, both of the Office of theSpeaker of the House, +1-202-226-7616
Source: PRNewswire-USNewswire
Related Articles
- BIO Testifies on Drug Safety Provisions of Draft FDA Globalization Act
- IT&Amp;E, Inc. Expands Compliance, Validation and Clinical Support Staffing Services to Meet FDA's Aggressive Drug Safety Monitoring
- Large Numbers of People Do Not Trust the Institutions They Identify As Most Responsible for Drug Safety
- FDA Seeks Higher Fees for Drug Safety
- Revamping the U.S. Drug Safety System: Cleveland Clinic's Steven Nissen, MD, Among Featured Participants at Windhover's FDA/CMS Summit
- FDA Selects Ingenix for Drug Safety Monitoring and Support
- HealthPartners Chief Health Officer Appointed to Federal Drug Safety Task Force
- Drug Safety to Be a Primary Focus at 10th Annual Drug Discovery Technology(R) & Development World Congress
- FDA to Create Drug Safety Director
 |
 |
User Comments (0)
RSS Feeds